OM Outset Medical, Inc.
Q3 2025 10-Q
Filed: Nov 10, 2025Period ending Sep 30, 2025
Health Care
Electromedical & Electrotherapeutic ApparatusSEC EDGAR Outset Medical, Inc. (OM) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 10, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ3 2025 10-Q
Risk Factors
- • New manufacturing risk from insourcing production in Mexico, partly triggered by ramping cartridge manufacturing and dependence on Mexico facility
- • Updated trade tariff risk due to Feb-Mar 2025 executive orders imposing 25% tariffs on Mexico and 20% on China imports, with ongoing Section 232 investigation
Quarterly Financial SummaryXBRL
Revenue
$29M
▲ +2.7% YoY▼ -6.3% QoQ
Net Income
-$18M
▲ +36.2% YoY▲ +3.8% QoQ
Gross Margin
39.4%
▲ +512bp YoY▲ +161bp QoQ
Operating Margin
-53.7%
▲ +2943bp YoY▼ -5bp QoQ
Net Margin
-60.6%
▲ +3686bp YoY▼ -160bp QoQ
ROE
-12.5%
Total Assets
$277M
EPS (Diluted)
$-0.80
▼ -50.9% YoY▼ -988.9% QoQ
Operating Cash Flow
-$6M
▲ +69.3% YoY▼ -31.0% QoQ
Source: XBRL data from Outset Medical, Inc. Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on Outset Medical, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.